A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...
The condition is characterized by recurring pain in the abdomen. Those with IBS may experience diarrhea, constipation, or both. Roughly 12% of the population in the United States have IBS. A person is ...